库马林曼尼希基衍生物的合成和抗瘤活性评估
Bing He1, Le Ding1, Hong-Zhou Tan1
1College of Pharmacy, Anhui University of Chinese Medicine, Hefei, China.
Chemical biology & drug design
|November 13, 2023
概括
合成了21种新的库马林曼尼赫基,并对抗扩散进行了测试. 化合物11g对肝癌 (HepG2) 细胞表现出强烈的活性,显示出更好的溶解性和对正常肝细胞的低毒性.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 癌症研究 癌症研究
背景情况:
- 库马林衍生物因其多样化的生物活性而得到认可.
- 曼尼克基是具有潜在治疗应用的多功能合成中间体.
- 开发新的抗增殖剂对于癌症治疗至关重要.
研究的目的:
- 合成和描述新的库马林曼尼赫基衍生物.
- 评估这些化合物对各种人类癌症细胞系的抗增殖潜力.
- 为了识别具有强大的抗癌活性和有利的物理化学特性的化合物.
主要方法:
- 21种库马林曼尼希基衍生物 (11a-u) 的合成.
- 针对HepG2,A549,MCF-7和HT-29癌细胞系的体外抗增殖试验.
- 氧化 (NO) 释放试验和对正常LO2细胞的细胞毒性研究.
- 在HepG2细胞上进行亡诱导研究.
主要成果:
- 所有合成的化合物都表现出反扩散活动.
- 化合物11g对HepG2细胞表现出最强的活性 (IC50 = 2.10μM),表现优于阳性对照5-FU.
- 化合物11g与化合物8相比,可溶性增加了13倍,对LO2细胞的毒性低.
- 化合物11g以度依赖的方式诱导HepG2细胞的亡,并显示出高NO释放 (10.8μM).
结论:
- 化合物11g是开发新型肝癌疗法的有希望的主要候选者.
- 合成的库马林曼尼希基代表了一类有价值的化合物,用于抗癌药物的发现.
- 需要对11g化合物的作用机制和体内疗效进行进一步的研究.
更多相关视频
相关概念视频
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.0K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.0K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K


